A note on the failure of CGP 19835 A (MTP-PE) to influence the course of influenza A2 infection in human volunteers
Antiviral ResearchPublished 1 August 1989
Peter G. Higgins, G. I. Barrow, Alan W. Galbraith, Heiner Frost, D. A. J. Tyrrell
Citations8
SJR quartileQ1
SJR score1.20
SNIP0.93
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A single dose of the immunomodulator CGP A (MTP-PE) given intranasally to human volunteers 24 h prior to challenge with influenza A2 virus failed to protect against infection or ameriolate any subsequent illness.
Abstract
A single dose of the immunomodulator CGP A (MTP-PE) given intranasally to human volunteers 24 h prior to challenge with influenza A2 virus failed to protect against infection or ameriolate any subsequent illness.
Keywords
Immunology and MicrobiologyMedicine
ScienceProtection of Mice Against Fatal Herpes Simplex Type 2 Infection by Liposomes Containing Muramyl Tripeptide
67 Citations1985Wayne C. Koff, S D Showalter +2 more
These findings suggest that the systemic activation of macrophages by liposomes containing an immunomodulator can lead to prophylaxis of severe infections caused by herpesviruses.
International Journal of ImmunopharmacologyEnhancement of host resistance against virus infections by MTP-PE, a synthetic lipophilic muramyl peptide — I. Increased survival in mice and guinea pigs after single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs
29 Citations1986Felix M. Dietrich, H. K. Hochkeppel +1 more
Muramyl tripeptide-phosphatidylethanolamine displays prophylactic antiviral activity in mice infected with influenza viruses A and B, parainfluenza 1 virus or herpes simplex type 1 viruses and in guinea pigs infected with HSV/2 viruses.